[ Price : $8.95]
Federal Register Proposed rule correction: FDA corrects an Internet address in an 8/8 Federal Register proposed rule requiring a P...[ Price : $8.95]
Federal Register Notice: FDA determines that Opana ER 7.5 mg and 15 mg were not withdrawn from sale for reasons of safety or effec...[ Price : $8.95]
Federal Register Notice: FDA determines that Talwin Compound tablets 325 mg were not withdrawn from sale for reasons of safety or ...[ Price : $8.95]
FDA sends NuPathe a complete response letter on an NDA for Zelrix (sumatriptan), a transdermal patch for treating migraine headach...[ Price : $8.95]
FDA warns Nanjing Biotech of CGMP problems at its China drug manufacturing facility.[ Price : $8.95]
FDA accepts for review a Progenics Pharmaceuticals supplemental NDA for Relistor (methylnaltrexone bromide) Subcutaneous Injection...[ Price : $8.95]
FDA issues a guidance on evaluating and labeling scored drug tablets.[ Price : $8.95]
FDA says a pilot program testing its Sentinel product surveillance system is up and running.